Alfuzosin

TERMINATED · PHASE3 · Prostatic Hyperplasia

Discontinued due to incomplete recruitment

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.